Accession Number: | 0001179110-19-002222 |
Date: | 2019-02-19 |
Issuer: | MOMENTA PHARMACEUTICALS INC (MNTA) |
Original Submission Date: |
BELTRAMELLO JO ANN
C/O MOMENTA PHARMACEUTICALS, INC.
301 BINNEY ST,
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-02-19 | S | 8,377 | d | $13.62 | 141,736 | direct | ||
COMMON STOCK | 2019-02-20 | S | 403 | d | $14.05 | 141,333 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | this transaction was effected pursuant to a rule 10b5-1 trading plan. |
f2 | this transaction was executed in multiple trades at prices ranging from $13.5675 to $13.71. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |